AHL
ALT icon

Abel Hall LLC’s Altimmune ALT Stock Holding History

Abel Hall LLC’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35K Buy
+11,527
New +$34.4K 0.01% 916

Other funds holding ALT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BWCS
Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return
BWM
Brown Wealth Management Naperville, Illinois $447M AUM 16.94% 1-Year Est. Return
SFWA
Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Abel Hall LLC's ALT Position: Q2 2026 in Review

Abel Hall LLC opened a new position in Altimmune (ALT) in Q2 2026: 11,527 shares worth $35K. The stake represents 0.01% of the portfolio and ranks #916 among its holdings.

35 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Abel Hall LLC held 11,527 shares of Altimmune worth $35K as of Q2 2026.
  • Altimmune was a new Abel Hall LLC position in Q2 2026.
  • Altimmune made up 0.01% of Abel Hall LLC's portfolio in Q2 2026, its #916 holding.
  • 35 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.